12345854664_8874aba15f_z

Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has entered a strategic collaboration with Thermo Fisher Scientific, in which Thermo Fisher will...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Fresenius Kabi and Formycon's ustekinumab biosimilar candidate, indicated for the...

REGENXBIO and Nippon Shinyaku have formed a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II (MPS II),...